Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study

Neuromuscular Disorders

Volumn 22, Issue 12, 2012, Pages 1069-1074

  Werlauff, U ^a   Vissing, J ^b   Steffensen, B F ^a  

^a The Danish National Rehabilitation Center for Neuromuscular Diseases   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Muscle strength; Natural history; Spinal muscular atrophy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARM WEAKNESS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; INFANT; LIMB WEAKNESS; LONGITUDINAL STUDY; MALE; MOTOR PERFORMANCE; MUSCLE STRENGTH; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; SPINAL MUSCULAR ATROPHY; TIME; WALKING DIFFICULTY;

ADOLESCENT; ADULT; AGED; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; TIME FACTORS; YOUNG ADULT;

EID: 84870392615     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.06.352     Document Type: Article

References (28)

1. Wirth B., Brichta L., Schrank B., et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 2002, 70:358-368.
2. Munsat T.L., Davies K.E. International SMA consortium meeting report. Neuromuscul Disord 1992, 2:423-428.
3. Zerres K., Rudnik-Schöneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestion for a modification of existing classifications. Arch Neurol 1995, 52:518-523.
4. Russman B.S., Buncher C.R., White M., Samaha F.J., Iannaccone S.T. Function changes in spinal muscular atrophy II and III. The DCN/SMA group. Neurology 1996, 47:973-976.
5. Swoboda K.J., Prior T.W., Scott C.B., et al. Natural history of denervation in SMA. Relation to age, SMN2 copy number and function. Ann Neurol 2005, 57:704-712.
6. Medical Research Council Aids to the investigation of peripheral nerve injuries 1976, Her Majesty's Stationary Office, London.
7. Werlauff U., Steffensen B.F., Bertelsen S., Fløytrup I., Kristensen B., Werge B. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscul Disord 2010, 1:34-43.
8. Carter G.T., Abresch R.T., Fowler W.M., et al. Profiles of neuromuscular diseases: spinal muscular atrophy. Am J Phys Med Rehabil 1995, 74:150-159.
9. Steffensen B.F., Lyager S., Werge B., Rahbek J., Mattsson E. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol 2002 Sep, 44:623-632.
10. Deymeer F., Serdaroglu P., Parman Y., Poda M. Natural history of SMA IIIb. Muscle strength decreases in a predictable sequence and magnitude. Neurology 2008, 71:644-649.
11. Souchon F., Simard L.R., Lebrun S., Rochette C., Lambert J., Vanasse M. Clinical and genetic study of chronic (types II and III) childhood onset spinal muscular atrophy. Neuromuscul Disord 1996 Dec, 6:419-424.
12. Merlini L., Bertini E., Minetti C., et al. Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve 2004, 29:548-552.
13. Iannaccone S.T., Russman B.S., Browne R.H., Buncher C.R., White M., Samaha F.J. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. J Child Neurol 2000, 15:97-101.
14. Kaufman P., McDermott M.P., Darras B.T., et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol 2011, 68:779-786.
15. Kaufmann P., Iannaccone S.T. Clinical trials in spinal muscular atrophy. Phys Med Rehabil Clin N Am 2008, 19:653-660.
16. Lyager S., Steffensen B., Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest 1995, 108(3):779-785.
17. Steffensen B.F., Hyde S.A., Lyager S., Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int 2001, 6:119-134.
18. Brooke M.H., Griggs R.C., Mendell J.R., et al. Clinical trial in Duchenne muscular dystrophy: I. The design of the protocol. Muscle Nerve 1981, 4:186-187.
19. Scott O.M., Hyde S.A., Goddard C., Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 1982, 5:291-301.
20. Liang K.Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 1996, 73(1):13-22.
21. Escolar D.M., Henricson E.K., Mayhew J., et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001, 24:787-793.
22. Florence J.M., Pandya S., King W., et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992, 72:115-122.
23. Kallman D.A., Plato C.C., Tobin J.D. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol 1990, 45:M82-M88.
24. Janssen I., Heymsfield S.B., Wang Z.M., Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88yr. J Appl Physiol 2000, 89:81-88.
25. Beenakker K.G., Ling C.H., Meskers C.G., et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 2010, 9:431-436.
26. Mahony K., Hunt A., Daley D., Sims S., Adams R. Inter-tester reliability and precision of manual muscle testing and hand-held dynamometry in lower limb muscles of children with spina bifida. Phys Occup Ther Pediatr 2009, 29:44-59.
27. Bosboom W.M., Vrancken A.F., van den Berg L.H., Wokke J.H., Iannaccone S.T. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev 2009, 1:CD006282.
28. Mazzone E., Bianco F., Martinelli, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord 2011, 6:406-412.